Literature DB >> 24658599

Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype.

Antony Cougnoux1, Guillaume Dalmasso1, Ruben Martinez2, Emmanuel Buc3, Julien Delmas4, Lucie Gibold4, Pierre Sauvanet3, Claude Darcha5, Pierre Déchelotte5, Mathilde Bonnet1, Denis Pezet3, Harald Wodrich2, Arlette Darfeuille-Michaud1, Richard Bonnet4.   

Abstract

BACKGROUND: Escherichia coli strains harbouring the pks island (pks+ E. coli) are often seen in human colorectal tumours and have a carcinogenic effect independent of inflammation in an AOM/IL-10(-/-) (azoxymethane/interleukin) mouse model.
OBJECTIVE: To investigate the mechanism sustaining pks+ E. coli-induced carcinogenesis.
METHOD: Underlying cell processes were investigated in vitro and in vivo (xenograft model) using intestinal epithelial cells infected by pks+ E. coli or by an isogenic mutant defective for pks (pks- E. coli). The results were supported by data obtained from an AOM/DSS (azoxymethane/dextran sodium sulphate) colon cancer mouse model and from human colon cancer biopsy specimens colonised by pks+ E. coli or pks- E. coli.
RESULTS: Colibactin-producing E. coli enhanced tumour growth in both xenograft and AOM/DSS models. Growth was sustained by cellular senescence (a direct consequence of small ubiquitin-like modifier (SUMO)-conjugated p53 accumulation), which was accompanied by the production of hepatocyte growth factor (HGF). The underlying mechanisms involve microRNA-20a-5p, which targets SENP1, a key protein regulating p53 deSUMOylation. These results are consistent with the expression of SENP1, microRNA-20a-5p, HGF and phosphorylation of HGF receptor found in human and mouse colon cancers colonised by pks+ E. coli.
CONCLUSION: These data reveal a new paradigm for carcinogenesis, in which colibactin-induced senescence has an important role. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Cell Proliferation; Colon Carcinogenesis; DNA Damage; E. Coli; Gene Expression

Mesh:

Substances:

Year:  2014        PMID: 24658599     DOI: 10.1136/gutjnl-2013-305257

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  159 in total

Review 1.  Structure and bioactivity of colibactin.

Authors:  Kevin M Wernke; Mengzhao Xue; Alina Tirla; Chung Sub Kim; Jason M Crawford; Seth B Herzon
Journal:  Bioorg Med Chem Lett       Date:  2020-05-23       Impact factor: 2.823

2.  Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.

Authors:  Kosuke Mima; Reiko Nishihara; Zhi Rong Qian; Yin Cao; Yasutaka Sukawa; Jonathan A Nowak; Juhong Yang; Ruoxu Dou; Yohei Masugi; Mingyang Song; Aleksandar D Kostic; Marios Giannakis; Susan Bullman; Danny A Milner; Hideo Baba; Edward L Giovannucci; Levi A Garraway; Gordon J Freeman; Glenn Dranoff; Wendy S Garrett; Curtis Huttenhower; Matthew Meyerson; Jeffrey A Meyerhardt; Andrew T Chan; Charles S Fuchs; Shuji Ogino
Journal:  Gut       Date:  2015-08-26       Impact factor: 23.059

Review 3.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

Review 4.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 5.  Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer.

Authors:  Aurélie Gagnaire; Bertrand Nadel; Didier Raoult; Jacques Neefjes; Jean-Pierre Gorvel
Journal:  Nat Rev Microbiol       Date:  2017-01-03       Impact factor: 60.633

Review 6.  When our genome is targeted by pathogenic bacteria.

Authors:  Claudie Lemercier
Journal:  Cell Mol Life Sci       Date:  2015-04-17       Impact factor: 9.261

Review 7.  Microbiome and cancer.

Authors:  Naoko Ohtani
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

8.  In Vitro Characterization of the Colibactin-Activating Peptidase ClbP Enables Development of a Fluorogenic Activity Probe.

Authors:  Matthew R Volpe; Matthew R Wilson; Carolyn A Brotherton; Ethan S Winter; Sheila E Johnson; Emily P Balskus
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

9.  The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment.

Authors:  Guillaume Dalmasso; Antony Cougnoux; Julien Delmas; Arlette Darfeuille-Michaud; Richard Bonnet
Journal:  Gut Microbes       Date:  2014

10.  Iron Homeostasis Regulates the Genotoxicity of Escherichia coli That Produces Colibactin.

Authors:  Sophie Tronnet; Christophe Garcie; Nadine Rehm; Ulrich Dobrindt; Eric Oswald; Patricia Martin
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.